Dublin, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/m5gpsl/cellular_therapy) has announced the addition of the "Cellular Therapy and the HSCT/Cord Blood Market Landscape" report to their offering.
In this comprehensive market report, the primary focus is on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field. This report analyzes clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and presents the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. Also presented are the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
The authors have also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. The report's coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood. Furthermore, given the author's global footprint, they've been able to compare the EU and US markets side-by-side in this analysis.
ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union are also given. Details on the statute as well as implications to companies seeking to navigate this space are provided.
Presented in this Report
For more information visit http://www.researchandmarkets.com/research/m5gpsl/cellular_therapy
Research and Markets Laura Wood, Senior Manager. press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology